Companies › LEXX

Lexaria Bioscience Corp (LEXX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001348362 · EDGAR filings · Updated 2026-07-13

Lexaria Bioscience Corp (LEXX) has reported institutional ownership of 6.0%, with 28 institutional managers holding positions valued at $1.17M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-13 — Quarterly report (10-Q) filed
• 2026-04-13 — Quarterly report (10-Q) filed
• 2026-03-18 — Insider transaction reported (Form 4)
• 2026-02-06 — Current report (8-K) filed
• 2026-01-28 — Current report (8-K) filed
• 2026-01-28 — Employee-plan registration (S-8) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Lexaria Bioscience Corp has 28 institutional holders and institutional ownership of 6.0%.

Insider activity

Insiders reported 7 transactions (6 buys, 0 sells) across 8 reporting insiders, with a net reported value of $49.1K.

Data flags from SEC filings

Related companies

ANBIO BIOTECHNOLOGY (NNNN) · BiomX Inc (PHGE) · PULSENMORE LTD (PLSM) · IGC PHARMA INC (IGC) · Alterity Therapeutics Ltd (ATHE) · VSee Health Inc (VSEE)